Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance

Journal of Neuroimmunology

Volumn 63, Issue 1, 1995, Pages 79-86

  Wang, Zeng Yu ^a   Bing, He ^a   Qiao, Jian ^a   Link, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmunity; Interferon gg; Interleukin 4; Oral tolerance; Transforming growth factor

Indexed keywords

CHOLINERGIC RECEPTOR; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; MYELIN BASIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG THERAPY; FEMALE; MYASTHENIA GRAVIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PREVENTION; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMAL; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; FEMALE; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-4; MYASTHENIA GRAVIS; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW; RECEPTORS, CHOLINERGIC; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TRANSFORMING GROWTH FACTOR BETA;

EID: 0028829252     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(95)00136-0     Document Type: Article

References (41)

1. Immunosuppressive therapy of autoimmune diseases
2. Suppression of experimental allergic encephalomyelitis by the oral administration of myelin basic protein
3. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon secreting cells
4. Sensitive mRNA detection of using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry
5. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species
6. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells
7. Cloning, expression and purification of rat IFN-γ
8. Lymphokine control of immuno-globulin isotype selection
9. Prevention of autoimmune demylination in non-human primates by a cAMP-specific phosphodiesterase inhibitor
10. Myasthe-nia gravis-like syndrome induced by expression of interferon-γ in the neuromuscular junction
11. Antigen-specific immunosuppres-sion: Oral tolerance for the treatment of autoimmune diseases
12. Anti-interferon treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses
13. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein and its fragments
14. Interferon-γ, interleukin-4 and transforming growth factor-β in experimental allergic encephalomyelitis in Lewis rats: Dynamics of cellular mRNA expression in the central nervous system and lymphoid cells
15. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery
16. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential upregulation of TGF-β, IL-4 and PGE expression in the brain
17. Myasthenia gravis
18. Identification of an encephalomyelitis determinant of myelin proteolipid protein for the rabbit
19. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls
20. Organ-specific autoantigens induce Interferon-γ and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis
21. Organ-specific autoantigens induce transforming growth factor-β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis
22. Interferon γ- and interleukin-4-secreting cells in multiple sclerosis
23. + T cells
24. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor-β after antigen-specific triggering
25. T cell immunity and interferon-γ secretion during experimental allergic encephalomyelitis in Lewis rats
26. Class II antigens and disease susceptibility
27. Oral administration of acetylcholine receptor: effects on experimental autoimmune myasthenia gravis
28. Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of interferom-gamma
29. Treatment of multiple sclerosis with gamma-interferon: Exacerbation associated with activation of the immune system
30. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune diseases
31. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
32. Differential induction of T cell cytokine mRNA in Epstein-Barr virus-transformed B cell clones: Constitutive and inducible expression of interleukin-4 mRNA
33. Spontaneous expression of IL-4 mRNA in lymphocytes from children with atopic dermatitis
34. The purification of rat gamma interferon by use of two mononuclear antibodies
35. IL-4 inhibits the synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures
36. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor
37. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis
38. T cell immunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis
39. Induction of interferon-y, interleukin-4 and transforming factor-β in rate orally tolerized against experimental autoimmune myasthenia gravis
40. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis
41. Oral tolerance in experimental allergic encephalomyelitis. III. Evidence for clonal anergy